07:00 , Sep 19, 2011 |  BC Week In Review  |  Company News

Spencer Pharmaceuticals Inc. deal

Spencer said its board recommended shareholders reject an offer from private equity firm Al-Dora Holdings to acquire the company. The company said it will continue to explore alternative opportunities. Details were not disclosed. In March,...
07:00 , Mar 28, 2011 |  BC Week In Review  |  Company News

Spencer Pharmaceuticals Inc. deal

Spencer announced that the expected closing date for its acquisition by private equity firm Al-Dora Holdings has been extended to the end of next quarter so the company can finalize and release undisclosed animal research...
08:00 , Jan 3, 2011 |  BC Week In Review  |  Company News

Spencer Pharmaceuticals Inc. deal

Spencer received a $500,000 deposit from a third-party corporate finance advisory firm as part of the ongoing $245 million acquisition by private equity firm Al-Dora Holdings. Spencer said the deposit will be used for ongoing...
08:00 , Dec 20, 2010 |  BC Week In Review  |  Company News

Spencer Pharmaceutical deal

Private equity firm Al-Dora Holdings will acquire Spencer for $245 million, or $1.10 per share, in cash (see BioCentury, Nov 22 & Dec. 13). Spencer Pharmaceutical Inc. (Pink:SPPH), Boston, Mass.   Business: Drug delivery   ...
08:00 , Dec 13, 2010 |  BC Week In Review  |  Company News

Spencer Pharmaceutical deal

Spencer will cancel 36 million previously issued shares and return them to the treasury. The company said the move would increase the share price of its previously announced acquisition by Al-Dora Holdings to $1.10 per...
08:00 , Nov 22, 2010 |  BC Week In Review  |  Company News

Spencer Pharmaceutical deal

Spencer's board said it is in favor of an offer from private equity firm Al-Dora Holdings, a subsidiary of the Al-Dora Group (Safat, Kuwait), to acquire the company for $0.97 per share in cash, or...